| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Ribosomal protein L10a (RPL10A) from ORIGENE TECHNOLOGIES | LY416199 | 100 ug | ORIGENE TECHNOLOGIES |
| Ribosomal protein L13a (RPL13A) from ORIGENE TECHNOLOGIES | LY402210 | 100 ug | ORIGENE TECHNOLOGIES |
| Ribosomal protein L23a (RPL23A) from ORIGENE TECHNOLOGIES | LY424414 | 100 ug | ORIGENE TECHNOLOGIES |
| Ribosomal protein L18a (RPL18A) from ORIGENE TECHNOLOGIES | LY424426 | 100 ug | ORIGENE TECHNOLOGIES |
| Ribosomal protein L35a (RPL35A) from ORIGENE TECHNOLOGIES | LY424408 | 100 ug | ORIGENE TECHNOLOGIES |
| Ribosomal protein L37a (RPL37A) from ORIGENE TECHNOLOGIES | LY400366 | 100 ug | ORIGENE TECHNOLOGIES |
| Ribosomal protein L27a (RPL27A) from ORIGENE TECHNOLOGIES | LY400357 | 100 ug | ORIGENE TECHNOLOGIES |
| Ribosomal protein L7a (RPL7A) from ORIGENE TECHNOLOGIES | LY424419 | 100 ug | ORIGENE TECHNOLOGIES |
| Ribosomal protein L36a (RPL36A) from ORIGENE TECHNOLOGIES | LY412151 | 100 ug | ORIGENE TECHNOLOGIES |
| Ribosomal protein L22-like 1 (RPL22L1) from ORIGENE TECHNOLOGIES | LY420471 | 100 ug | ORIGENE TECHNOLOGIES |
| Ribosomal protein L26-like 1 (RPL26L1) from ORIGENE TECHNOLOGIES | LY414197 | 100 ug | ORIGENE TECHNOLOGIES |
| Ribosomal protein L7-like 1 (RPL7L1) from ORIGENE TECHNOLOGIES | LY404920 | 100 ug | ORIGENE TECHNOLOGIES |
| Ribosomal protein L11 (RPL11) from ORIGENE TECHNOLOGIES | LY424421 | 100 ug | ORIGENE TECHNOLOGIES |
| Ribosomal protein L39-like (RPL39L) from ORIGENE TECHNOLOGIES | LY409319 | 100 ug | ORIGENE TECHNOLOGIES |
| Ribosomal protein L12 (RPL12) from ORIGENE TECHNOLOGIES | LY424422 | 100 ug | ORIGENE TECHNOLOGIES |
| Ribosomal protein L15 (RPL15) from ORIGENE TECHNOLOGIES | LY418995 | 100 ug | ORIGENE TECHNOLOGIES |
| Ribosomal protein L19 (RPL19) from ORIGENE TECHNOLOGIES | LY400353 | 100 ug | ORIGENE TECHNOLOGIES |
| Ribosomal protein L18 (RPL18) from ORIGENE TECHNOLOGIES | LY424425 | 100 ug | ORIGENE TECHNOLOGIES |
| Leukemia inhibitory factor receptor alpha (LIFR), transcript variant 2 from ORIGENE TECHNOLOGIES | LY419401 | 100 ug | ORIGENE TECHNOLOGIES |
| Leukocyte-associated immunoglobulin-like receptor 2 (LAIR2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY411982 | 100 ug | ORIGENE TECHNOLOGIES |
| Leukemia inhibitory factor receptor alpha (LIFR), transcript variant 1 from ORIGENE TECHNOLOGIES | LY426848 | 100 ug | ORIGENE TECHNOLOGIES |
| Leukemia NUP98 fusion partner 1 (LNP1) from ORIGENE TECHNOLOGIES | LY421302 | 100 ug | ORIGENE TECHNOLOGIES |
| Leukocyte-associated immunoglobulin-like receptor 1 (LAIR1), transcript variant a from ORIGENE TECHNOLOGIES | LY419415 | 100 ug | ORIGENE TECHNOLOGIES |
| Leukocyte-associated immunoglobulin-like receptor 1 (LAIR1), transcript variant b from ORIGENE TECHNOLOGIES | LY411939 | 100 ug | ORIGENE TECHNOLOGIES |
| Leukocyte-associated immunoglobulin-like receptor 1 (LAIR1), transcript variant b from ORIGENE TECHNOLOGIES | LY429656 | 100 ug | ORIGENE TECHNOLOGIES |
| Leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3 (LILRA3) from ORIGENE TECHNOLOGIES | LY416372 | 100 ug | ORIGENE TECHNOLOGIES |
| Leukocyte cell derived chemotaxin 1 (LECT1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY416253 | 100 ug | ORIGENE TECHNOLOGIES |
| Leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3 (LILRA3), transcript variant 2 from ORIGENE TECHNOLOGIES | LY432960 | 100 ug | ORIGENE TECHNOLOGIES |
| Leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1 (LILRA1) from ORIGENE TECHNOLOGIES | LY416370 | 100 ug | ORIGENE TECHNOLOGIES |
| Leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6 (LILRA6) from ORIGENE TECHNOLOGIES | LY411315 | 100 ug | ORIGENE TECHNOLOGIES |
| Leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4 (LILRA4) from ORIGENE TECHNOLOGIES | LY415845 | 100 ug | ORIGENE TECHNOLOGIES |
| Leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 (LILRA2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY416373 | 100 ug | ORIGENE TECHNOLOGIES |
| Leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 (LILRA5), transcript variant 2 from ORIGENE TECHNOLOGIES | LY405584 | 100 ug | ORIGENE TECHNOLOGIES |
| Leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 (LILRA5), transcript variant 1 from ORIGENE TECHNOLOGIES | LY411987 | 100 ug | ORIGENE TECHNOLOGIES |
| Leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 (LILRB1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY416494 | 100 ug | ORIGENE TECHNOLOGIES |
| Leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 (LILRA5), transcript variant 4 from ORIGENE TECHNOLOGIES | LY405585 | 100 ug | ORIGENE TECHNOLOGIES |
| Leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 (LILRB2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY421144 | 100 ug | ORIGENE TECHNOLOGIES |
| Leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 (LILRB2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY401781 | 100 ug | ORIGENE TECHNOLOGIES |
| Leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 (LILRB3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY421154 | 100 ug | ORIGENE TECHNOLOGIES |
| Leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 (LILRB3), transcript variant 2 from ORIGENE TECHNOLOGIES | LY416371 | 100 ug | ORIGENE TECHNOLOGIES |
| Leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4 (LILRB4), transcript variant 1 from ORIGENE TECHNOLOGIES | LY416380 | 100 ug | ORIGENE TECHNOLOGIES |
| Leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4 (LILRB4), transcript variant 2 from ORIGENE TECHNOLOGIES | LY421151 | 100 ug | ORIGENE TECHNOLOGIES |
| Leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4 (LILRB4), transcript variant 2 from ORIGENE TECHNOLOGIES | LY425932 | 100 ug | ORIGENE TECHNOLOGIES |
| FUS - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN201808 | 1 kit | ORIGENE TECHNOLOGIES |
| Fused in sarcoma (FUS), transcript variant 1 from ORIGENE TECHNOLOGIES | LY401541 | 100 ug | ORIGENE TECHNOLOGIES |
| FUS - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN201808LP | 1 kit | ORIGENE TECHNOLOGIES |
| FUS - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN201808RB | 1 kit | ORIGENE TECHNOLOGIES |
| FUS - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN201808BN | 1 kit | ORIGENE TECHNOLOGIES |
| FUS - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN401808 | 1 kit | ORIGENE TECHNOLOGIES |
| FUT8 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN212345 | 1 kit | ORIGENE TECHNOLOGIES |